Show simple item record

dc.contributor.authorTepper, Naomi K.
dc.contributor.authorGoldberg, Howard I.
dc.contributor.authorBernal, Manuel I. Vargas
dc.contributor.authoret al.
dc.date.accessioned2022-09-05T17:00:22Z
dc.date.available2022-09-05T17:00:22Z
dc.date.issued2016-06
dc.identifier.urihttps://www.cdc.gov/mmwr/volumes/65/wr/mm6512e1.htm#T1_downen_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/2950
dc.description.abstractZika virus is a flavivirus transmitted primarily by Aedes species mosquitoes. Increasing evidence links Zika virus infection during pregnancy to adverse pregnancy and birth outcomes, including pregnancy loss, intrauterine growth restriction, eye defects, congenital brain abnormalities, and other fetal abnormalities (1,2). The virus has also been determined to be sexually transmitted.* Because of the potential risks associated with Zika virus infection during pregnancy, CDC has recommended that health care providers discuss prevention of unintended pregnancy with women and couples who reside in areas of active Zika virus transmission and do not want to become pregnant.(†) However, limitations in access to contraception in some of these areas might affect the ability to prevent an unintended pregnancy. As of March 16, 2016, the highest number of Zika virus disease cases in the United States and U.S. territories were reported from Puerto Rico.(§) The number of cases will likely rise with increasing mosquito activity in affected areas, resulting in increased risk for transmission to pregnant women. High rates of unintended and adolescent pregnancies in Puerto Rico suggest that, in the context of this outbreak, access to contraception might need to be improved (3,4). CDC estimates that 138,000 women of reproductive age (aged 15-44 years) in Puerto Rico do not desire pregnancy and are not using one of the most effective or moderately effective contraceptive methods,(¶)(,)** and therefore might experience an unintended pregnancy. CDC and other federal and local partners are seeking to expand access to contraception for these persons. Such efforts have the potential to increase contraceptive access and use, reduce unintended pregnancies, and lead to fewer adverse pregnancy and birth outcomes associated with Zika virus infection during pregnancy. The assessment of challenges and resources related to contraceptive access in Puerto Rico might be a useful model for other areas with active transmission of Zika virus.en_US
dc.languageEnglishen_US
dc.subjectZika Research Projecten_US
dc.subjectZika Virusen_US
dc.subjectZika Virus Infectionen_US
dc.subjectZika Virus Diseaseen_US
dc.subjectAccess to Contraceptionen_US
dc.subjectPuerto Ricoen_US
dc.titleEstimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak - Puerto Rico, 2016en_US
eihealth.countryOthersen_US
eihealth.categoryEpidemiology and epidemiological studiesen_US
eihealth.typeResearch protocol informationen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalMorbidity and Mortality Weekly Report (MMWR)en_US
dc.contributor.corporatenameUnited States of America. National Center for Chronic Disease Prevention and Health Promotionen_US
dc.contributor.corporatenameUnited States of America. Puerto Rico Department of Healthen_US
dc.contributor.corporatenameUnited States of America. National Center on Birth Defects and Developmental Disabilitiesen_US
dc.contributor.corporatenameUnited States of America. Health Resources and Services Administrationen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record